Ítem
Solo Metadatos

Prevalence of HPV-DNA and anti-HPV antibodies in women from girardot, Colombia

Mostrar el registro sencillo de la publicación
dc.creatorLeon, Sandraspa
dc.creatorSánchez, Ricardospa
dc.creatorPatarroyo, Manuel A.
dc.creatorCamargo, Milenaspa
dc.creatorMejia, Adrianospa
dc.creatorUrquiza, Mauriciospa
dc.creatorPatarroyo, Manuel Espa
dc.date.accessioned2020-08-19T14:40:14Z
dc.date.available2020-08-19T14:40:14Z
dc.date.created2009-05spa
dc.description.abstractObjective: To assess the frequency of HPV-DNA detection, human papillomavirus (HPV) seropositivity, presence of cervical lesions, and its relationship with certain socio-demographic factors in women from Girardot, Colombia from 2006 to 2007. Methods: Nine hundred fifty-three women attending their regular Pap smear control voluntarily provided cervical cells and blood samples for HPV-DNA analysis and ELISA detection of anti-L1 peptides and virus-like particles (VLPs) antibodies after answering a questionnaire regarding sexual behaviors, number of births, smoking habits, and socio-demographic background. Results: Twenty-six of the 953 women being examined (2.73%) presented cervical cell abnormalities. A frequency of 36.62% (95% CI: 33.52%–39.7%) HPV seropositivity was detected with peptide 18301, 35.36% (95% CI: 32.3%–38.4%) with 18283, and 32.95% (95% CI: 29.9%–36%) with 18294, whereas VLPs detected a 43% seropositivity (95% CI: 39.8%– 46.2%). Antibody frequency found with all peptides was significantly higher in women having cervical abnormalities (atypical squamous cells of undetermined significance and high-grade squamous intraephitelial lesions) compared with those having normal cytologies. Peptide 18283 reported a significantly higher seropositivity (35.71%) in women 44 years old, whereas peptides 18301 and 18294 evidenced a significantly lower seropositivity in those who had never given birth. HR-HPV-DNA was detected in 157 (20.50%) of 766 cervical samples amplifying positively for the -globin housekeeping gene. Conclusion: Peptides 18283, 18294, and 18301 were more specific and more sensitive than VLPs for detecting women with HR-HPV-DNA positive cervical lesions. Therefore, they could be useful in the design of a serological test for detecting HR-HPV-infected women having cervical lesions at a risk of progressing to cervical cancer.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1097/OLQ.0b013e318195762c
dc.identifier.issnISSN: 0148-5717
dc.identifier.issnEISSN: 1537-4521
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/26786
dc.language.isoengspa
dc.publisherAmerican Sexually Transmitted Diseases Associationspa
dc.relation.citationEndPage296
dc.relation.citationIssueNo. 5
dc.relation.citationStartPage290
dc.relation.citationTitleSexually Transmitted Diseases, Journal of the American Venereal Disease Association
dc.relation.citationVolumeVol. 35
dc.relation.ispartofSexually Transmitted Diseases, Journal of the American Venereal Disease Association, ISSN: 0148-5717;EISSN: 1537-4521, Vol.35, No.5 (May 2009); pp. 290-296spa
dc.relation.urihttps://journals.lww.com/stdjournal/Fulltext/2009/05000/Prevalence_of_HPV_DNA_and_Anti_HPV_Antibodies_in.5.aspxspa
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.rights.accesoAbierto (Texto Completo)spa
dc.sourceSexually Transmitted Diseases, Journal of the American Venereal Disease Associationspa
dc.source.instnameinstname:Universidad del Rosario
dc.source.reponamereponame:Repositorio Institucional EdocUR
dc.subject.keywordPapilloma virus infections complicationsspa
dc.subject.keywordSeroepidemiologic studiesspa
dc.subject.keywordUterine cervical neoplasms / epidemiologyspa
dc.subject.keywordFemalespa
dc.titlePrevalence of HPV-DNA and anti-HPV antibodies in women from girardot, Colombiaspa
dc.title.TranslatedTitlePrevalencia de VPH-ADN y anticuerpos anti-VPH en mujeres de girardot, Colombiaspa
dc.typearticleeng
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersion
dc.type.spaArtículospa
Archivos
Colecciones
Artículos